Enhancing Fairness in AI/ML Models for Healthcare Using Real-World Data

By Charmi Patel

May 22, 2024

Introduction

The latest research in artificial intelligence (AI) and machine learning (ML) has completely transformed healthcare industry, providing solutions for risk prediction, disease diagnosis, and outcome forecasting. The integration of AI/ML with real-world data (RWD) has shown promise in improving healthcare decision-making processes. However, concerns about algorithmic bias and fairness have emerged, emphasising the need for comprehensive research in this area.

Understanding Algorithmic Bias in Healthcare

Algorithmic fairness in AI/ML applications is crucial to prevent biases that could disproportionately impact different societal groups. Furthermore, examples from healthcare, such as biassed health cost predictions and disparities in disease outcomes, underscore the importance of fair AI/ML practices in healthcare settings.

Assessing Fairness in AI/ML Models

Researchers use metrics such as equality of opportunity, predictive parity, and statistical parity to assess fairness in ML models. Subsequently, they commonly apply pre-processing techniques like reweighing and data imputation to mitigate bias and improve fairness in healthcare applications.

Mitigating Bias in Healthcare AI/ML

Studies have explored pre-processing, in-processing, and post-processing methods to address bias in ML models. Furthermore, techniques such as recalibration and reweighing have shown promise in improving fairness and reducing disparities in healthcare predictions.

Future Research and Recommendations

Future research should focus on expanding fair ML practices into multi-modality and unstructured data. Consequently, this enhances model interpretability, addressing biases in data collection and governance. Collaborative efforts among AI experts, healthcare professionals, and ethicists are essential to ensure the ethical and equitable use of AI/ML in healthcare settings.

Advancing fair AI/ML practices in healthcare with RWD highlights the need for ongoing research. This promotes trustworthy and inclusive healthcare decision-making processes. Continuous exploration in this field is crucial. Lastly, it highlights the critical nature of ongoing investigations in advancing healthcare AI/ML practices.

The Role of Explainable AI in Healthcare

Explainable AI plays a vital role in healthcare by providing transparency and interpretability in AI/ML models, aiding in understanding how decisions are made and increasing trust in the technology.

Reference url

Recent Posts

NovoCare Pharmacy Wegovy
         

NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access

🌟 Did you know that access to essential obesity medications can significantly impact health outcomes?

NovoCare Pharmacy has just launched an innovative direct-to-patient delivery program for Wegovy (semaglutide) at a new, lower price of $499 per month for those uninsured or underinsured. This groundbreaking initiative not only enhances access to FDA-approved medication but also prioritizes patient safety by minimizing the risks of counterfeit alternatives.

Eager to learn more about how this is reshaping the obesity treatment landscape? Dive into the full article!

#SyenzaNews #HealthEconomics #MarketAccess

maternal child health Africa
   

Maternal Child Health in South Africa

🌍 How does economic growth truly impact maternal and child health in Africa?

While economic growth can lead to improved health outcomes, its effects are inconsistent and heavily influenced by socio-economic factors. Key elements like female education and effective governance are essential for maximizing these benefits.

Dive into our latest article to uncover the complexities at play and the critical policy implications for enhancing health outcomes in the region.

#SyenzaNews #globalhealth #healthcarepolicy

tuberculosis burden children
   

Tackling the Tuberculosis Burden in Children: A Global Perspective

🌍 Did you know the global burden of tuberculosis (TB) among children has dropped significantly over the past three decades?

Our recent analysis reveals a remarkable 37.4% reduction in TB incidence and a staggering 71.7% decrease in deaths from 1990 to 2021. Yet, challenges persist, especially in low SDI regions where this public health threat continues to expose disparities in healthcare access and outcomes.

Look into the full article to explore these critical insights and the implications for future strategies in TB management.

#SyenzaNews #globalhealth #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.